Gene Review:
BIRC5 - baculoviral IAP repeat containing 5
Homo sapiens
Synonyms:
API4, Apoptosis inhibitor 4, Apoptosis inhibitor survivin, Baculoviral IAP repeat-containing protein 5, EPR-1, ...
Storlazzi,
Brekke,
Mandahl,
Brosjö,
Smeland,
Lothe,
Mertens,
Hopkins-Donaldson,
Belyanskaya,
Simões-Wüst,
Sigrist,
Kurtz,
Zangemeister-Wittke,
Stahel,
Mahlamäki,
Bärlund,
Tanner,
Gorunova,
Höglund,
Karhu,
Kallioniemi,
Schneider,
Morano,
Gigena,
Missawa,
Rocha,
Silva,
Ellert,
Kataoka,
Katsuragi,
Rosa,
Filho,
Freier,
Pungs,
Sticht,
Flechtenmacher,
Lichter,
Joos,
Hofele,
Kokkinakis,
Brickner,
Kirkwood,
Liu,
Goldwasser,
Kastrama,
Sander,
Bocangel,
Chada,
Oe,
Nagashima,
Muramoto,
Yamazaki,
Morikawa,
Okitsu,
Nishimura,
Aoki,
Katayama,
Kita,
Span,
Tjan-Heijnen,
Heuvel,
de Kok,
Foekens,
Sweep,
- Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. Liu, X., Chen, N., Wang, X., He, Y., Chen, X., Huang, Y., Yin, W., Zhou, Q. J. Neuropathol. Exp. Neurol. (2006)
- Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Tracey, L., Pérez-Rosado, A., Artiga, M.J., Camacho, F.I., Rodríguez, A., Martínez, N., Ruiz-Ballesteros, E., Mollejo, M., Martinez, B., Cuadros, M., Garcia, J.F., Lawler, M., Piris, M.A. J. Pathol. (2005)
- Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Span, P.N., Tjan-Heijnen, V.C., Heuvel, J.J., de Kok, J.B., Foekens, J.A., Sweep, F.C. Clin. Chem. (2006)
- High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy. Freier, K., Pungs, S., Sticht, C., Flechtenmacher, C., Lichter, P., Joos, S., Hofele, C. Int. J. Cancer (2007)
- In vivo immunosuppression by targeting a novel protease receptor. Duchosal, M.A., Rothermel, A.L., McConahey, P.J., Dixon, F.J., Altieri, D.C. Nature (1996)
- Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Li, F., Ackermann, E.J., Bennett, C.F., Rothermel, A.L., Plescia, J., Tognin, S., Villa, A., Marchisio, P.C., Altieri, D.C. Nat. Cell Biol. (1999)
- Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. Herbert, J., Bono, F., Herault, J., Avril, C., Dol, F., Mares, A., Schaeffer, P. J. Clin. Invest. (1998)
- Inhibition of melanoma tumor growth in vivo by survivin targeting. Grossman, D., Kim, P.J., Schechner, J.S., Altieri, D.C. Proc. Natl. Acad. Sci. U.S.A. (2001)
- Protease receptors in Hodgkin's disease: expression of the factor Xa receptor, effector cell protease receptor-1, in Reed-Sternberg cells. Adida, C., Ambrosini, G., Plescia, J., Crotty, P.L., Costa, J., Altieri, D.C. Blood (1996)
- Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Mahlamäki, E.H., Bärlund, M., Tanner, M., Gorunova, L., Höglund, M., Karhu, R., Kallioniemi, A. Genes Chromosomes Cancer (2002)
- Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress. Kokkinakis, D.M., Brickner, A.G., Kirkwood, J.M., Liu, X., Goldwasser, J.E., Kastrama, A., Sander, C., Bocangel, D., Chada, S. Mol. Cancer Res. (2006)
- Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Bono, F., Schaeffer, P., Hérault, J.P., Michaux, C., Nestor, A.L., Guillemot, J.C., Herbert, J.M. Arterioscler. Thromb. Vasc. Biol. (2000)
- Xa receptor EPR-1. Altieri, D.C. FASEB J. (1995)
- Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours. Storlazzi, C.T., Brekke, H.R., Mandahl, N., Brosjö, O., Smeland, S., Lothe, R.A., Mertens, F. J. Pathol. (2006)
- Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa. Altieri, D.C. J. Biol. Chem. (1994)
- CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells. Oe, T., Nagashima, T., Muramoto, M., Yamazaki, T., Morikawa, N., Okitsu, O., Nishimura, S., Aoki, T., Katayama, Y., Kita, Y. Neuropharmacology (2006)
- Contamination levels and preliminary assessment of the technical feasibility of employing natural attenuation in 5 priority areas of presidente bernardes refinery in cubatão, são paulo, Brazil. Schneider, R.P., Morano, S.C., Gigena, M.A., Missawa, S.K., Rocha, R.C., Silva, L.R., Ellert, N., Kataoka, S., Katsuragi, C., Rosa, C.d.a. .S., Filho, L.C. Environmental monitoring and assessment. (2006)
- p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma. Hopkins-Donaldson, S., Belyanskaya, L.L., Simões-Wüst, A.P., Sigrist, B., Kurtz, S., Zangemeister-Wittke, U., Stahel, R. Neoplasia (2006)
- Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Mesri, M., Morales-Ruiz, M., Ackermann, E.J., Bennett, C.F., Pober, J.S., Sessa, W.C., Altieri, D.C. Am. J. Pathol. (2001)
- Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Bowen, A.R., Hanks, A.N., Murphy, K.J., Florell, S.R., Grossman, D. The American Journal of dermatopathology. (2004)